// IP Marketing video - START// IP Marketing video - END

Nestle confirms acquisition of Pfizer's infant nutrition business

Nestle confirms acquisition of Pfizer's infant nutrition business

PanARMENIAN.Net - Swiss food group Nestle said on Monday, April 23 it would buy U.S. drugmaker Pfizer's infant nutrition business for $11.85 billion, beating out French rival Danone as both sought to gain preeminence in the lucrative baby food market.

"Its strong brands and product portfolio, its talented people dedicated to the success of its business, together with its geographic presence - 85 percent of its sales are in emerging markets - will complement our existing infant nutrition business perfectly," Nestle Chief Executive Paul Bulcke said, Reuters reported.

Nestle reported earlier that first-quarter sales rose a healthy 5.6 percent from a year earlier, fueled by strong growth in emerging markets and higher retail prices.

The sales amounted to 21.39 billion Swiss francs ($23.34 billion), though demand in developed markets was subdued amid global financial uncertainty in the United States - its biggest market - and Europe. Sales in developed countries grew 3.1 percent, compared with a 13 percent rise in emerging markets.

 Top stories
Armenia's foreign debt amounts to $4.3 billion as of March 2017, while that of the central bank totaled $517.9 million.
According to Vardanyan, IDeA and its partners and donors have since 2007 invested more than $550 million in various projects in Armenia.
75.8 million kWh of Armenian electricity have been shipped to the Georgian market in the first quarter of 2017.
The government has made a decision to allocate to Sastex the building of the former regional hospital and the adjacent areas.
Partner news